Continued Late Conversion to Complete Remission (CR/CRu) and Durability of Remission (DUR) in Pts with B-Cell Follicular Lymphoma (FL) Treated with Rituximab Followed by Mitumprotimut-T (Id-KLH, FavId®) Active Immunotherapy.
| Autor: | Koc, Omer N., Redfern, Charles *, Wiernik, Peter H., Rosenfelt, Fred *, Winter, Jane N., Guthrie, Troy H., Kaplan, Lawrence, Holman, Peter, Densmore, John, Hainsworth, John, Lin, Thomas S., Castillo, Rene A., Janakiraman, Nalini, Ghalie, Richard G. |
|---|---|
| Zdroj: | In Blood 16 November 2007 110(11):3427-3427 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|